Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer

Molecular Carcinogenesis

Volumn 53, Issue 4, 2014, Pages 280-285

  Liu, Jiaming ^a   Huang, Jin ^a   He, Yazhou ^a   Liu, Jinnan ^a   Liao, Banghua ^a   Liao, Ga ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

ITG; Micro RNA binding sites; Polymorphism; Prostate carcinoma

Indexed keywords

INTEGRIN; MICRORNA;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BINDING SITE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CONTROLLED STUDY; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ITG; MICRO-RNA BINDING SITES; POLYMORPHISM; PROSTATE CARCINOMA;

BASE SEQUENCE; BINDING SITES; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTEGRINS; MALE; MICRORNAS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 84895816246     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21973     Document Type: Article

References (34)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29.
2. Ferlay J, Bray F, Pisani P, et al. Global cancer 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer-Base No 5, version 2.0. Lyon: IARC Press; 2004.
3. Hynes RO. Integrins: Versatility, modulation and signalling in cell adhesion. Cell 1992; 69:11-25.
4. Humphries MJ. Integrin Structure. Biochem Soc T 2000; 28:311-339.
5. Clezardin P. Recent insights into the role of integrins in cancer metastasis. Cell Mol Life Sci 1998; 54:541-548.
6. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Bio 2004; 5:816-826.
7. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requies focal adhesion kinase signaling. J Clin Invest 2009; 119:252-266.
8. Bao W, Stromblad S. Integrin αv-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen. J Cell Biol 2004; 167:745-756.
9. Varner JA, Emerson DA, Juliano RL. Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 1995; 6:725-740.
10. Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10:9-22.
11. Marthick JR, Dickinson JL. Emerging putative biomarkers: The role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosis. Prostate Cancer 2012; 2012:298732.
12. McCabe NP, De S, Vasanji A, et al. Prostate cancer specific integrin αvβ3 modulates bone metastatic growth and tissue. Oncogene 2007; 26:6238-6243.
13. Eeles RA, Kote-Jarai Z, Al Olama AA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009; 41:1116-1121.
14. Cheng I, Plummer SJ, Neslund-Dudas C, et al. Prostate cancer susceptibility variants confer increased risk of disease progression. Cancer Epidemiol Biomarkers Prev 2010; 19:2124-2132.
15. FitzGerald LM, Patterson B, Thomson R, et al. Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. Eur J Hum Genet 2009; 17:368-377.
16. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
17. Kumar MS, Lu J, Mercer KL, et al. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39:673-677.
18. Brennecke J, Stark A, Russell RB, et al. Principles of microRNA-target recognition. PLoS Biol 2005; 3:e85.
19. Abelson JF, Kwan KY, O'Roak BJ, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005; 310:317-320.
20. Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3'untranslated region: a mechanism for functional single-nucleatide polymorphisms related to phenotypes. Am J Hum Genet 2007; 81:405-413.
21. Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008; 29:579-584.
22. Brendle A, Lei H, Brandt A, et al. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 2008; 29:1394-1399.
23. Saetrom P, Biesinger J, Li SM, et al. A risk variant in a miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 2009; 69:7459-7465.
24. Chin LJ, Ratner E, Leng S, et al. A SNP in a let-7 microRNA complementary site in the KRAS3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008; 68:8535-8540.
25. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15:97-98.
26. Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: Update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009; 19:519-523.
27. Goel HL, Li J, Kogan S, Languino LR. Integrins in prostate cancer progression. Endocr-relat Cancer 2008; 15:657-664.
28. Drivalos A, Papatsoris AG, Chrisofos M, Efstathiou E, Dimopoulos MA. The role of the cell adhesion molecules (integrins/cadherins) in prostate cancer. Int Braz J Urol 2011; 37:302-306.
29. Cooper CR, Chay CH, Pienta KJ. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 2002; 4:191-194.
30. De S, Chen J, Narizhneva NV, et al. Molecular pathway for cancer metastasis to bone. J Biol Chem 2003; 278:39044-39050.
31. van den Hoogen C, van der Horst G, Cheung H, et al. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. Am J Pathol 2011; 179:2559-2568.
32. Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008; 105:15535-15540.
33. Ichimi T, Enokida H, Okuno Y, et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 2009; 125:345-352.
34. Schepeler T, Holm A, Halvey P, et al. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene 2011; 31:2750-2760.